世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Middle East Patient Engagement Solutions Market Size, Share & Trends Analysis Report By Type (AI-Driven Engagement, Telehealth Solutions), By Delivery (Web/Cloud-based, On-premise), By Functionality, By End-use, By Country, And Segment Forecasts, 2025 - 2033

Middle East Patient Engagement Solutions Market Size, Share & Trends Analysis Report By Type (AI-Driven Engagement, Telehealth Solutions), By Delivery (Web/Cloud-based, On-premise), By Functionality, By End-use, By Country, And Segment Forecasts, 2025 - 2033


Market Size & Trends The Middle East patient engagement solutions market size was estimated at USD 689.25 million in 2024 and is projected to reach USD 4,527.63 million by 2033, growing at a CA... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
Grand View Research
グランドビューリサーチ
2025年8月29日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
電子ファイル - ご注文後3営業日前後 90 英語

 

Summary

Market Size & Trends

The Middle East patient engagement solutions market size was estimated at USD 689.25 million in 2024 and is projected to reach USD 4,527.63 million by 2033, growing at a CAGR of 23.45% from 2025 to 2033. Growing technological developments, adoption of electronic health record (EHR) and mhealth solutions, the prevalence of chronic diseases, supportive initiatives by key market stakeholders, and consumerism in healthcare are some of the key drivers of this market.

Moreover, the rising focus on digital health transformation across the Middle East, coupled with government-driven healthcare modernization initiatives and public-private partnerships, is expected to significantly propel the adoption of patient engagement solutions across the region throughout the forecast period.

The Middle East patient engagement solutions industry is experiencing significant growth fueled by national digital health transformation initiatives, rising smartphone usage, and an increasing emphasis on value-based care. Governments in countries like the UAE and Saudi Arabia are actively investing in digital infrastructure as part of initiatives such as UAE Vision 2031 and Saudi Vision 2030, which focus on enhancing healthcare access and patient-centered care. In addition, as of October 2024, the UAE’s Riayati platform, part of the National Unified Medical Record (NUMR) initiative, has connected over 14 million unique patients, 4 billion medical records, 4,952 healthcare facilities, and 116,071 clinicians, providing a unified, seamless record-sharing experience across the country.

Another example of the region’s digital health progress is Saudi Arabia’s 2022 partnership with global health data provider Orion Health to develop the world’s largest health information exchange (HIE). The platform aims to unify data from over 5,000 government and private healthcare institutions, creating a complete view of patient records for 32 million people, with the ability to expand beyond 50 million. This extensive interoperable network allows clinicians to access detailed medication histories, lab results, diagnostic data, and more enhancing safer clinical decisions, preventive care, and quick interventions. Such infrastructure not only improves national healthcare services but also opens doors to using AI and machine learning for managing chronic illnesses, detecting outbreaks, and improving population health-a strategic step in line with Vision 2030’s goal for a tech-driven, patient-focused healthcare system.

Middle East Patient Engagement Solutions Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East patient engagement solutions market report based on type, delivery mode, functionality, end use, and country:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• AI-Driven Engagement
• Telehealth Solutions
• Patient Portals
• Remote Patient Monitoring
• Population Health Management
• Appointment and Medication Reminders
• Others
• Delivery Mode Outlook (Revenue, USD Million, 2021 - 2033)
• Web/Cloud-based
• On-Premise
• Functionality Outlook (Revenue, USD Million, 2021 - 2033)
• Enhanced Communication
• Patient Education
• Predictive Analytics
• Streamlined Operations
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Healthcare Providers
o Outpatient Facility
o Inpatient Facility
• Healthcare Payers
o Private
o Public
• Pharmaceutical Companies (Pharma)
• Pharmacy
o Independent Pharmacies (Nuclear Pharmacies)
o Community Pharmacies
o Mail-Order Pharmacies
o Retail Pharmacies
o Digital Pharmacies
o Specialty Pharmacies
o Central Fill Pharmacies
o Compounding Pharmacies
o Others (Alternate dispensing site, Closed door)
• Country Outlook (Revenue, USD Million, 2021 - 2033)
• Saudi Arabia
• UAE
• Kuwait
• Qatar
• Oman

ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Delivery mode
1.2.3. Functionality
1.2.4. End use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Shift toward patient-centered care
3.2.1.2. Growing digitalization in healthcare industry
3.2.1.3. Rising government initiatives
3.2.1.4. Rapid technological advancements such as AI, machine learning, and advanced analytics
3.2.2. Market Restraint Analysis
3.2.2.1. Data Privacy and Security Concerns
3.2.2.2. Inconsistent Digital Infrastructure Across Some Countries
3.2.3. Industry Opportunity Analysis
3.2.4. Industry Challenge Analysis
3.2.5. Case Studies
3.3. Business Environment Analysis
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal Landscape
Chapter 4. Middle East Patient Engagement Solutions Market: Type Estimates & Trend Analysis
4.1. Type Segment Dashboard
4.2. Type Market Share Movement Analysis, 2024 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million)
4.4. AI-Driven Engagement
4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Telehealth Solutions
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Patient Portals
4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Remote Patient Monitoring
4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Population Health Management
4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.9. Appointment and Medication Reminders
4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East Patient Engagement Solutions Market: Delivery Mode Estimates & Trend Analysis
5.1. Delivery Mode Dashboard
5.2. Delivery Mode Market Share Movement Analysis, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analysis, by Delivery Mode, 2021 to 2033 (USD Million)
5.4. Web/Cloud based
5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. On-premise
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East Patient Engagement Solutions Market: Functionality Estimates & Trend Analysis
6.1. Functionality Segment Dashboard
6.2. Functionality Market Share Movement Analysis, 2024 & 2033
6.3. Market Size & Forecasts and Trend Analysis, by Functionality, 2021 to 2033 (USD Million)
6.4. Enhanced Communication
6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Patient Education
6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Predictive Analytics
6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Streamlined Operations
6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Others
6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Middle East Patient Engagement Solutions Market: End Use Estimates & Trend Analysis
7.1. End Use Segment Dashboard
7.2. End Use Market Share Movement Analysis, 2024 & 2033
7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Healthcare Providers
7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.2. Outpatient Facility
7.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.3. Inpatient Facility
7.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Healthcare Payers
7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.2. Private
7.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.3. Public
7.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Pharmaceutical Companies (Pharma)
7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Pharmacy
7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.2. Independent Pharmacies (Nuclear Pharmacies)
7.7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.3. Community Pharmacies
7.7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.4. Mail-Order Pharmacies
7.7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.5. Retail Pharmacies
7.7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.6. Digital Pharmacies
7.7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.7. Specialty Pharmacies
7.7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.8. Central Fill Pharmacies
7.7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.9. Compounding Pharmacies
7.7.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.10. Others (Alternate dispensing site, Closed door)
7.7.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Middle East Patient Engagement Solutions Market: Country Estimates & Trend Analysis
8.1. Country Market Dashboard
8.2. Country Market: Key Takeaways
8.2.1. Saudi Arabia
8.2.1.1. Key country dynamic
8.2.1.2. Regulatory framework
8.2.1.3. Competitive insights
8.2.1.4. Saudi Arabia patient engagement solutions market estimates and forecasts, 2021 - 2033 (USD Million)
8.2.2. UAE
8.2.2.1. Key country dynamic
8.2.2.2. Regulatory framework
8.2.2.3. Competitive insights
8.2.2.4. UAE patient engagement solutions market estimates and forecasts, 2021 - 2033 (USD Million)
8.2.3. Kuwait
8.2.3.1. Key country dynamic
8.2.3.2. Regulatory framework
8.2.3.3. Competitive insights
8.2.3.4. Kuwait patient engagement solutions market estimates and forecasts, 2021 - 2033 (USD Million)
8.2.4. Qatar
8.2.4.1. Key country dynamic
8.2.4.2. Regulatory framework
8.2.4.3. Competitive insights
8.2.4.4. Qatar patient engagement solutions market estimates and forecasts, 2021 - 2033 (USD Million)
8.2.5. Oman
8.2.5.1. Key country dynamic
8.2.5.2. Regulatory framework
8.2.5.3. Competitive insights
8.2.5.4. Oman patient engagement solutions market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. Cerner Corporation (Oracle)
9.5.1.1. Overview
9.5.1.2. Financial performance
9.5.1.3. Product benchmarking
9.5.1.4. Strategic initiatives
9.5.2. Epic Systems Corporation
9.5.2.1. Overview
9.5.2.2. Financial performance
9.5.2.3. Product benchmarking
9.5.2.4. Strategic initiatives
9.5.3. InterSystems
9.5.3.1. Overview
9.5.3.2. Financial performance
9.5.3.3. Product benchmarking
9.5.3.4. Strategic initiatives
9.5.4. Shifa.net
9.5.4.1. Overview
9.5.4.2. Financial performance
9.5.4.3. Product benchmarking
9.5.4.4. Strategic initiatives
9.5.5. McKesson Corporation
9.5.5.1. Overview
9.5.5.2. Financial performance
9.5.5.3. Product benchmarking
9.5.5.4. Strategic initiatives
9.5.6. NextGen Healthcare, Inc.
9.5.6.1. Overview
9.5.6.2. Financial performance
9.5.6.3. Product benchmarking
9.5.6.4. Strategic initiatives
9.5.7. Klara Technologies, Inc.
9.5.7.1. Overview
9.5.7.2. Financial performance
9.5.7.3. Product benchmarking
9.5.7.4. Strategic initiatives
9.5.8. CPSI, Ltd.
9.5.8.1. Overview
9.5.8.2. Financial performance
9.5.8.3. Product benchmarking
9.5.8.4. Strategic initiatives
9.5.9. Experian Information Solutions, Inc.
9.5.9.1. Overview
9.5.9.2. Financial performance
9.5.9.3. Product benchmarking
9.5.9.4. Strategic initiatives
9.5.10. Athenahealth
9.5.10.1. Overview
9.5.10.2. Financial performance
9.5.10.3. Product benchmarking
9.5.10.4. Strategic initiatives
9.5.11. Solutionreach, Inc.
9.5.11.1. Overview
9.5.11.2. Financial performance
9.5.11.3. Product benchmarking
9.5.11.4. Strategic initiatives
9.5.12. IBM
9.5.12.1. Overview
9.5.12.2. Financial performance
9.5.12.3. Product benchmarking
9.5.12.4. Strategic initiatives
9.5.13. MEDHOST
9.5.13.1. Overview
9.5.13.2. Financial performance
9.5.13.3. Product benchmarking
9.5.13.4. Strategic initiatives
9.5.14. Nuance Communications, Inc.
9.5.14.1. Overview
9.5.14.2. Financial performance
9.5.14.3. Product benchmarking
9.5.14.4. Strategic initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療IT)の最新刊レポート

Grand View Research社の ヘルスケアIT分野 での最新刊レポート

本レポートと同じKEY WORD(telehealth)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2025/10/22 10:26

152.71 円

177.57 円

206.90 円

ページTOPに戻る